Tyra Biosciences, Inc.
TYRA· Nasdaq
Tyra Biosciences, Inc.
- Last sale
- Oct 1, 2026 · -3.91%
- Market cap
- $1.25B
- 59.68M shares
- Filings
- 425
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $102,928,000 | reported | |
| FY 2024 | 2024-12-31 | $80,077,000 | reported | |
| FY 2023 | 2023-12-31 | $62,518,000 | reported | |
| FY 2022 | 2022-12-31 | $43,008,000 | reported | |
| FY 2021 | 2021-12-31 | $20,636,000 | reported | |
| FY 2020 | 2020-12-31 | $7,203,000 | reported |
Tyra Biosciences, Inc. · CIK 1863127 · Engraved from SEC EDGAR
